Command Palette

Search for a command to run...

SMSPHARMA
277.89(+1.18%)
1W: +11.80%

SMS Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Revenue growth of 48% in the latest quarter signals strong market demand.
  • Net profit increased to ₹20.49 crore, showing improved profitability.
  • Operating profit margin rose, indicating effective cost management.
NEGATIVES
  • Expenses increased significantly in recent quarters, impacting profit margins.
  • Material costs remain high, affecting overall profitability.
  • Fluctuating other income suggests inconsistent revenue streams.

Quarterly Results Data (Numbers are in Crore)

FieldTrendJun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Jun 25
Revenue
135.34166.64161.48245.80164.45196.75173.35196.05
Expenses
123.17152.29146.45225.71143.99178.51153.04172.27
Operating Profit
12.1714.3515.0420.0920.4618.2420.3123.78
Other Income
0.510.811.491.651.371.312.130.59
Interest
6.325.575.955.614.674.614.205.84
Depreciation
7.697.908.017.928.388.628.709.75
Profit Before Tax
13.2114.8415.7122.9621.9319.7823.6026.14
Tax
3.873.114.245.695.465.685.365.65
Net Profit
9.3411.7211.4817.2816.4814.1018.2420.49
Eps in Rs
1.101.391.362.041.951.672.152.31

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.